Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?

M K Kägi

Journal: Dermatology (Basel, Switzerland) 2002;203(4):280-3

PMID: 11752812

Full Text on S. Karger AG, Basel, Switzerland View on PubMed

Abstract

Cysteinyl leukotrienes have been shown to be important in the pathogenesis of both asthma and rhinitis. Improvement of skin manifestations in atopic dermatitis has been reported with leukotriene receptor antagonists. This article reviews current data on the experimental evidence and clinical efficacy of leukotriene receptor antagonists in the treatment of atopic dermatitis.

Address: Private Praxis for Dermatology, Allergy and Clinical Immunology, Zürich, Switzerland. [email protected]

DOI: 10.1159/000051772

Link outs

Subscription / membership required

Full Text Sources:

https://doi.org/10.1159/000051772

MeSH Terms: Acetates, Cyclopropanes, Dermatitis, Atopic, Humans, Leukotriene Antagonists, Leukotrienes, Quinolines, Sulfides, Urticaria